Johnson & Johnson COVID vaccine on hold due to rare blood clots

The Food and Drug Administration and the Centers for Disease Control and Prevention say they'll be investigating the rare blood clots from the Johnson & Johnson COVID vaccine. It comes at a time when demand is increasing as eligibility becomes widespread in California.